Rep. Dan Crenshaw

Maddy summaryThis bill reauthorizes and improves federal programs focused on preventing, detecting, and treating traumatic brain injuries (TBIs), extending funding through 2030. It updates CDC surveillance to better track high-risk groups (like military personnel, first responders, and those in certain occupations) and requires public sharing of aggregated TBI data. States receiving grants must maintain non-Federal funding levels for TBI programs, with limited waivers allowed. The bill also mandates a congressional report on high-risk populations and a study examining long-term TBI effects, including links to dementia and mental health conditions.

Maddy summaryHR 1266, the Combating Illicit Xylazine Act, adds xylazine - a veterinary sedative increasingly found in illicit drug mixtures - to Schedule III of the Controlled Substances Act, regulating its use and trafficking. It directly affects veterinarians, animal owners, and manufacturers by allowing xylazine to be legally dispensed for animal use under specific veterinary prescriptions, while prohibiting non-veterinary human use. The bill includes transition periods (60 days for practitioners, 1 year for labeling) to ease compliance for manufacturers and practitioners, and requires the DEA and FDA to expedite necessary applications. It also mandates two congressional reports on xylazine's illicit use and trafficking patterns, and directs the Sentencing Commission to review penalties for offenses involving xylazine.

Maddy summaryThis resolution honors the late Senator Lindsey Graham and condemns Omar Suleiman for publicly celebrating Graham's death. It also acknowledges that House Democrats invited Suleiman to serve as a guest chaplain in 2019 and highlights his past statements and affiliations. The measure expresses support for the House Republicans' Sharia-Free America Caucus, which aims to protect constitutional principles from what it describes as an ideology incompatible with American life.

Maddy summaryHR 5880, the "Fight Illicit Pill Presses Act," requires manufacturers and distributors of pill-making machines (like tableting machines) and their critical parts (such as punches and dies) to affix permanent serial numbers to these items. It mandates that these businesses report transactions involving such machines to the Attorney General and maintain records of the serial numbers. The law prohibits tampering with or knowingly distributing machines with removed or altered serial numbers. This directly affects manufacturers, distributors, and sellers of these specific pill-production machines and parts, aiming to improve tracking of equipment used in illicit drug manufacturing.

Maddy summaryThis bill requires Medicare Advantage plans to implement electronic pre-approval systems for medical services by 2028 and meet transparency reporting standards starting in 2027. Plans must publicly report data on approval/denial rates, appeal outcomes, response times, and technology use for pre-approval requests, including details on how denials relate to clinical criteria. It establishes a 24-hour response timeframe for certain requests and mandates annual reviews of pre-approval requirements based on data and input from seniors and providers. The law directly affects Medicare Advantage plans, seniors enrolled in these plans, and healthcare providers who submit pre-approval requests. These changes aim to make the pre-approval process faster, more transparent, and more accountable for seniors seeking covered medical services.

Protecting Privacy in Purchases Act This bill prohibits payment card networks from using merchant codes that distinguish firearms retailers from general-merchandise retailers or sporting-goods retailers. The Department of Justice must enforce this bill and report annually on the resulting investigations and cases.

Maddy summaryThis bill requires the Medicare program to ensure specific electronic reporting methods (like digital clinical quality measures) are available for Accountable Care Organizations (ACOs) participating in the Medicare Shared Savings Program from 2025 through 2029. It clarifies that ACOs won’t be penalized for missing data from certain participants if they meet other reporting rules and demonstrate the participant couldn’t collect data via the required digital method. Additionally, it creates a voluntary pilot program (2028-2032) where selected ACOs report only two quality measures digitally instead of all required measures, with special rules about how this data affects performance scoring. The bill directly affects MSSP ACOs and changes their quality reporting requirements and flexibility.

Maddy summaryThe Critical Infrastructure Airspace Defense Act grants owners and operators of designated high-risk facilities, such as nuclear power plants and key electrical substations, the legal authority to detect, track, and disable unauthorized drones threatening their security. To exercise this power, personnel must complete a federally mandated training and certification program that establishes standards for legal and technical proficiency before they can use approved counter-drone technologies. The legislation also creates a $250 million grant program to help these facilities purchase and install the necessary equipment while providing liability protection for authorized actions taken to mitigate threats. Additionally, the bill requires the Department of Homeland Security to issue implementing regulations within 180 days and mandates regular reports on the program's activities to Congress.

Maddy summaryThe SECURE 340B Act strengthens oversight of the drug discount program for safety-net health care providers by establishing clearer definitions for patients and prescribing providers, requiring detailed record-keeping to prove a legitimate patient relationship. The bill introduces strict rules for contract pharmacies, mandating that manufacturers cannot restrict discounts based on their use and requiring full transparency on where these drugs are dispensed. It also expands eligibility for child sites of covered entities while imposing a new community need standard based on geographic vulnerability scores to prevent abuse. To improve program integrity, the legislation creates a centralized data clearinghouse to track claims and prevent duplicate discounts, while simultaneously prohibiting discriminatory practices by insurance companies and pharmacy benefit managers against covered entities. Finally, the Act authorizes new user fees and additional funding for the Health Resources and Services Administration to support expanded audits and enforcement activities.

Maddy summaryThis bill directs the Department of Defense to review clinical trial data on psilocybin treatment for veterans and servicemembers with treatment-resistant PTSD. It requires the Assistant Secretary of Defense for Health Affairs to submit a report within 180 days analyzing the safety, dosing, and feasibility of these findings for military personnel, including those transitioning to civilian life. The report must also assess legal requirements for expanded access to the substance and outline plans for future pilot programs or research starting in fiscal year 2027. Additionally, the legislation mandates coordination with the Department of Veterans Affairs and other federal agencies to ensure continuity of care and appropriate regulatory oversight.